An anti-HIV microbicide comes alive.
Lagenaur
Laurel A
LA
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Berger
Edward A
EA
D000818:Animals; D019380:Anti-HIV Agents / Q000378:metabolism*; D004926:Escherichia coli / Q000235:genetics; D005818:Genetic Engineering / Q000379:methods*; D015483:HIV Antibodies / Q000378:metabolism; D015700:HIV Envelope Protein gp41 / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology; D015497:HIV-1 / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D010446:Peptide Fragments / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology; D019936:Probiotics; D015728:Receptors, HIV / Q000378:metabolism
D019380:Anti-HIV Agents; D015483:HIV Antibodies; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments; D015728:Receptors, HIV